Evaluation of Nisin and LL-37 Antimicrobial Peptides as Tool to Preserve Articular Cartilage Healing in a Septic Environment.
Najmi. Ziba Z; Kumar. Ajay A; Scalia. Alessandro C AC; Cochis. Andrea A; Obradovic. Bojana B; Grassi. Federico A FA; Leigheb. Massimiliano M; Lamghari. Meriem M; Loinaz. Iraida I; Gracia. Raquel R; Rimondini. Lia L
Key Findings
- Nisin (75 µg/ml) is more cytocompatible than LL‑37 for human mesenchymal stem cells
- Both peptides kill Gram‑positive (S. aureus, S. epidermidis) and Gram‑negative (E. coli, A. actinomycetemcomitans) bacteria, with Nisin showing stronger activity
- The antibacterial effect holds in 3‑D cartilage spheroids and a perfusion bioreactor mimicking infection conditions
Practical Outcomes
- For DIY enthusiasts interested in antimicrobial strategies, Nisin appears to be a safer and more potent option than LL‑37 for local use on cartilage repair devices at ~75 µg/ml. However, its application is limited to topical or scaffold‑based settings, not systemic use, and further validation is needed before real‑world protocols.
Summary
The study tested two antimicrobial peptides, Nisin and LL‑37, to see if they can keep joint‑repair scaffolds from getting infected. They found that Nisin at about 75 µg/ml is safe for human stem cells and kills several common bacteria better than LL‑37, even in 3‑D cartilage‑like models.
Abstract
Cartilage repair still represents a challenge for clinicians and only few effective therapies are nowadays available. In fact, surgery is limited by the tissue poor self-healing capacity while the autologous transplantation is often forsaken due to the poor <i>in vitro</i> expansion capacity of chondrocytes. Biomaterials science offers a unique alternative based on the replacement of the injured tissue with an artificial tissue-mimicking scaffold. However, the implantation surgical practices and the scaffold itself can be a source of bacterial infection that currently represents the first reason of implants failure due to the increasing antibiotics resistance of pathogens. So, alternative antibacterial tools to prevent infections and consequent device removal are urgently required. In this work, the role of Nisin and LL-37 peptides has been investigated as alternative to antibiotics to their antimicrobial performances for direct application at the surgical site or as doping chemicals for devices aimed at articular cartilage repair. First, peptides cytocompatibility was investigated toward human mesenchymal stem cells to determine safe concentrations; then, the broad-range antibacterial activity was verified toward the Gram-positive <i>Staphylococcus aureus</i> and <i>Staphylococcus epidermidis</i> as well as the Gram-negative <i>Escherichia coli</i> and <i>Aggregatibacter actinomycetemcomitans</i> pathogens. The peptides selective antibacterial activity was verified by a cells-bacteria co-culture assay, while chondrogenesis was assayed to exclude any interference within the differentiation route to simulate the tissue repair. In the next phase, the experiments were repeated by moving from the cell monolayer model to 3D cartilage-like spheroids to revisit the peptides activity in a more physiologically relevant environment model. Finally, the spheroid model was applied in a perfusion bioreactor to simulate an infection in the presence of circulating peptides within a physiological environment. Results suggested that 75 μg/ml Nisin can be considered as a very promising candidate since it was shown to be more cytocompatible and potent against the investigated bacteria than LL-37 in all the tested models.
Study Information
pubmed
2020
2020-06-12T00:00:00.000Z
10.3389/fbioe.2020.00561
22
79